Companion diagnostics

Saliva sampling could be the key to fast, affordable, and accurate breast cancer screening

A pathologist's tribute to Yanyong Jiang – Chinese surgeon and SARS hero who passed away at the age of 92

Towards a world where NGS-based companion diagnostics are available, in house, for every new cancer therapy and every patient

The ever-developing tale of companion diagnostic tests in precision oncology

Closer pathology-oncology care team coordination is key to leverage the value of precision therapies and improve outcomes

How companion diagnostic tests are helping cancer patients find personalized answers – and treatments – fast

Users share their experiences with the Ion Torrent™ Genexus™ platform over the two years since the technology was introduced to the lab community

David Rimm continues the conversation about the best assay for atezolizumab after a recent response to his original article

Emina Torlakovic and Allen Gown share their disagreements with David Rimm’s comments about an FDA-approved PD-L1 assay for atezolizumab

Not every assay that trials well is practical for implementation in daily practice. How can we tell which ones are, and whose responsibility is it?